Италия - итальянский - Ministero della Salute

idt biologika gmbh - immunoglobulina da cane, anticorpi contro la parvovirosi, anticorpi contro il cimurro, virus inattivato dell' epatite infettiva del cane - immunoglobulina da cane - 170 mg; anticorpi contro la parvovirosi - 1 : 10000; anticorpi contro il cimurro - 5000 ui; virus inattivato dell' epatite infettiva del cane - 1000 ui - canine distemper antiserum + canine adenovirus antiserum + canine parvovirus antiserum

Италия - итальянский - Ministero della Salute

zoetis belgium sa - mycoplasma hyopneumoniae inattivato ceppo p-5722-3, circovirus suino chimerico tipo 1 inattivato che esprime la proteina orf2 del circovirus suino tipo 2, inattivato, circovirus suino di tipo 1 che esprime la proteina orf2 del circovirus suino tipo 2, inattivato - mycoplasma hyopneumoniae inattivato ceppo p-5722-3 - nd r.p.; circovirus suino chimerico tipo 1 inattivato che esprime la proteina orf2 del circovirus suino tipo 2; inattivato - nd r.p.; circovirus suino di tipo 1 che esprime la proteina orf2 del circovirus suino tipo 2; inattivato - nd r.p., circovirus suino chimerico tipo 1 inattivato che esprime la proteina orf2 del circovirus suino tipo 2; inattivato - nd r.p.; mycoplasma hyopneumoniae inattivato ceppo p-5722-3 - nd r.p.; circovirus suino di tipo 1 che esprime la proteina orf2 del circovirus suino tipo 2; inattivato - nd r.p., circovirus suino di tipo 1 che esprime la proteina orf2 del circovirus suino tipo 2; inattivato - nd r.p.; mycoplasma hyopneumoniae inattivato ceppo p-5722-3 - nd r.p.; circovirus suino chimerico tipo 1 inattivato che esprime la proteina orf2 del circovirus suino tipo 2; inattivato - nd r.p., mycoplasma hyopneumoniae inattivato ceppo p-5722-3 - nd r.p.; circovirus suino chimerico ricombinante inattivato tipo 1 che esprime la protein - porcine circovirus + mycoplasma

Европейский союз - итальянский - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - prodotti immunologici per felidae, - gatti - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

Европейский союз - итальянский - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - prodotti immunologici per felidae, - gatti - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Европейский союз - итальянский - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - prodotti immunologici per felidae, - gatti - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Италия - итальянский - Ministero della Salute

united vaccines holding b. v. - clostridium botolinum tipo c -tossoide - clostridium botolinum tipo c -tossoide - nd, tossoide batterico di clostridium botolinum tipo c (ceppo sa) - nd - mink enteritisvirus /parvovirus + clostridium + pseudomonas

Италия - итальянский - Ministero della Salute

idt biologika gmbh - pseudomonas aeruginosa sierotipi pab 5, tossoide batterico di clostridium botolinum tipo c (ceppo sa), virus enterite del visone (mev), 0 tcid50/dose - pseudomonas aeruginosa sierotipi pab 5 - 1 x(10 alla 8) cellule per sierotipo; tossoide batterico di clostridium botolinum tipo c (ceppo sa) - 2.5 x(10 alla 4) mld100; virus enterite del visone (mev) - 10 elevato alla 4; 0 tcid50/dose - mink enteritisvirus /parvovirus + clostridium + pseudomonas

Европейский союз - итальянский - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosoppressori - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Италия - итальянский - Ministero della Salute

zoetis italia s.r.l. - virus attenuato omologo della parvovirosi canina, ceppo nl-35-d - virus attenuato omologo della parvovirosi canina; ceppo nl-35-d - 10 elevato alla 7 tcid50 - canine parvovirus

Италия - итальянский - Ministero della Salute

zoetis italia s.r.l. - virus vivo attenuato della panleucopenia felina, ceppo snow leopard - virus vivo attenuato della panleucopenia felina; ceppo snow leopard - 10 elevato alla 3 ccid50 - feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus